Understanding the role of Prostaglandin D2 in chronic skin allergies
Functional Characterization of Prostaglandin D2 in Chronic Spontaneous Urticaria
This study is looking into how a substance called Prostaglandin D2 might be causing allergic reactions in people with chronic spontaneous urticaria (CSU), which affects about 1 in 100 people, to help find new treatment options for those who aren't getting better with current medicines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10660944 on NIH RePORTER |
What this research studies
This research investigates how Prostaglandin D2 (PGD2) contributes to chronic spontaneous urticaria (CSU), a condition affecting about 1% of the population. The study aims to uncover the mechanisms by which PGD2 activates immune cells and skin cells, leading to allergic reactions. By analyzing skin biopsies from patients with CSU, the research will explore the inflammatory processes involved and seek to identify potential new treatment targets for those who do not respond to existing therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic spontaneous urticaria who have not found relief with current FDA-approved treatments.
Not a fit: Patients with acute urticaria or those whose symptoms are linked to identifiable triggers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for patients suffering from chronic spontaneous urticaria.
How similar studies have performed: Previous research has shown promising results in understanding the role of inflammatory mediators in allergic conditions, suggesting that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Oliver, Eric T — Johns Hopkins University
- Study coordinator: Oliver, Eric T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.